Literature DB >> 21064090

Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted form.

C Mongaret1, J Alexandre, A Thomas-Schoemann, E Bermudez, C Chéreau, C Nicco, F Goldwasser, B Weill, F Batteux, F Lemare.   

Abstract

Oxidative stress plays a role in the regulation of cancer cell metastasis which involves cell invasion and adhesion that could be supported by ADAM proteins through the activities of their metalloprotease and disintegrin domains. We hypothesized that oxidative stress could act through the induction of ADAM9 protein in some cancer cells. Indeed, Western blot analysis for ADAM9 performed on A549 cells exposed to H(2) O(2) reveals a dose-dependent induction of two proteins (80 and 68 kDa) correlated with a sharp increase of the ADAM protease activity measured in supernatant while the activity measured on the cell layer was slightly affected. The 80kDa protein corresponds to the mature form of ADAM9. Immunoprecipitation analysis performed on concentrated supernatants revealed that the 68 kDa protein is a secreted form of ADAM9. When exposed to H(2) O(2) , A549 cells cocultured with confluent endothelial vascular cells resulted in a 5.5 fold (p < 0.001) increase in the number of adherent cells. Similarly, matrigel assay revealed a 3.25 fold (p < 0.01) increase in the number of invasive cells. The suppression of ADAM9 expression by specific small interfering RNA reduced oxidative stress-induced invasiveness and adhesiveness. These functions could be mediated by an interaction between ADAM9 and β1 integrin because each of them were inhibited when the experiment is performed in presence of mAbs targeting ADAM9 ectodomain or β1-integrin. These results emphasize the importance of oxidative stress in the regulation of cancer cell metastasis and suggest that ADAM9 and its secreted isoform can be important determinants in the ability of cancer cells to disseminate.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21064090     DOI: 10.1002/ijc.25746

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Secretome signature of invasive glioblastoma multiforme.

Authors:  Catherine A Formolo; Russell Williams; Heather Gordish-Dressman; Tobey J MacDonald; Norman H Lee; Yetrib Hathout
Journal:  J Proteome Res       Date:  2011-05-31       Impact factor: 4.466

2.  Deletion of ADAM-9 in HGF/CDK4 mice impairs melanoma development and metastasis.

Authors:  N Giebeler; A Schönefuß; J Landsberg; T Tüting; C Mauch; P Zigrino
Journal:  Oncogene       Date:  2017-05-29       Impact factor: 9.867

3.  Acquired xanthine dehydrogenase expression shortens survival in patients with resected adenocarcinoma of lung.

Authors:  Hayato Konno; Yoshihiro Minamiya; Hajime Saito; Kazuhiro Imai; Yasushi Kawaharada; Satoru Motoyama; Jun-ichi Ogawa
Journal:  Tumour Biol       Date:  2012-06-08

Review 4.  The pleiotropic roles of ADAM9 in the biology of solid tumors.

Authors:  Victor O Oria; Paul Lopatta; Oliver Schilling
Journal:  Cell Mol Life Sci       Date:  2018-03-17       Impact factor: 9.261

5.  Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma.

Authors:  T Kauttu; H Mustonen; S Vainionpää; L Krogerus; I Ilonen; J Räsänen; J Salo; P Puolakkainen
Journal:  Clin Transl Oncol       Date:  2016-03-30       Impact factor: 3.405

Review 6.  Regulating surgical oncotaxis to improve the outcomes in cancer patients.

Authors:  Toshihiro Hirai; Hideo Matsumoto; Hisako Kubota; Yoshiyuki Yamaguchi
Journal:  Surg Today       Date:  2013-06-05       Impact factor: 2.549

7.  miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma.

Authors:  Nadia Felli; Federica Felicetti; Anna Maria Lustri; M Cristina Errico; Lisabianca Bottero; Alessio Cannistraci; Alessandra De Feo; Marina Petrini; Francesca Pedini; Mauro Biffoni; Ester Alvino; Massimo Negrini; Manuela Ferracin; Gianfranco Mattia; Alessandra Carè
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

8.  Convergence of genetic influences in comorbidity.

Authors:  Richard C McEachin; Keerthi S Sannareddy; James D Cavalcoli; Alla Karnovsky; Jacqueline M Vink; Maureen A Sartor
Journal:  BMC Bioinformatics       Date:  2012-03-13       Impact factor: 3.169

9.  Loss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signaling.

Authors:  Shamik Das; William P Jackson; Jeevan K Prasain; Ann Hanna; Sarah K Bailey; J Allan Tucker; Sejong Bae; Landon S Wilson; Rajeev S Samant; Stephen Barnes; Lalita A Shevde
Journal:  Sci Rep       Date:  2017-01-23       Impact factor: 4.379

10.  ADAM9 is over-expressed in human ovarian clear cell carcinomas and suppresses cisplatin-induced cell death.

Authors:  Mari Ueno; Takayuki Shiomi; Satsuki Mochizuki; Miyuki Chijiiwa; Masayuki Shimoda; Yae Kanai; Fumio Kataoka; Akira Hirasawa; Nobuyuki Susumu; Daisuke Aoki; Yasunori Okada
Journal:  Cancer Sci       Date:  2018-02       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.